ZURA Earnings & Financial Statements
Zura Bio Limited
$4.41
+$0.18(+4.26%)
36
Overall
60
Value
27
Tech
21
Quality
Market Cap
$422.61M
Volume
5.74M
52W Range
$3.15 - $7.44
Target Price
$18.83
ZURA earnings and financial statements: Zura Bio Limited's income statement, balance sheet and cash flow statement, annual and quarterly.
ZURA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$75.25M | -$55.19M | -$62.64M | -$27.16M | -$888.5K |
| EBITDA | -$68.65M | -$52.39M | -$60.60M | -$27.16M | $10.39M |
| Net income | -$68.70M | -$52.40M | -$60.40M | -$25.74M | $6.85M |
| EPS (diluted) | $-1.06 | $-0.60 | $-2.09 | $0.21 | $1.22 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $113.95M | $179.53M | $100.84M | $5.26M | $140.55M |
| Total liabilities | $12.41M | $19.51M | $21.29M | $14.82M | $10.35M |
| Shareholders’ equity | $101.54M | $146.81M | $59.33M | -$32.06M | -$9.18M |
| Cash and equivalents | $109.40M | $176.50M | $99.81M | $1.57M | $729.2K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$64.81M | -$28.08M | -$15.05M | -$1.20M | -$1.10M |
| Capital expenditure | -$113.0K | -$75.0K | -$8.00M | -$12.00M | - |
| Free cash flow | -$64.93M | -$28.15M | -$23.05M | -$13.20M | -$1.10M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZURA | $4.41 | +4.3% | 5.74M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |